Literature DB >> 17653761

Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.

Fausto Sessa1, Daniela Furlan, Clementina Zampatti, Ileana Carnevali, Francesca Franzi, Carlo Capella.   

Abstract

Prognostic factors for ampullary carcinomas (ACs) are poorly defined. Fifty three resected ACs were analyzed for CDX2, MUC1, MUC5AC, MUC6, MUC2, and for mismatch repair proteins (hMLH1, hMSH2, PMS2, hMSH6) using immunohistochemistry. Microsatellite instability (MSI) status was evaluated by fluorescently labeled PCR using an automated sequencer. Univariate and multivariate analysis was performed for clinicopathological, immunohistochemical and molecular parameters. CDX2 was found in 32 out of 53 (60%) ACs with a significantly higher frequency among intestinal ACs compared with biliopancreatic (BP) ACs. The MUC1, MUC5AC, MUC6, MUC2 apomucins were expressed in 75, 43, 39, and 28% of ACs, respectively, with a significantly higher coexpression of MUC1/MUC5AC in BP ACs. MSI and loss of expression of hMLH1/PMS2 or hMSH2/hMSH6 proteins were observed only in intestinal ACs. Factors significantly correlated with improved survival in the univariate analysis were: low stage, absence of lymph nodes metastases, negative surgical margins (R0 status), and presence of MSI. In the multivariate analysis, stage was the only independent prognostic factor of survival. We conclude that stage is the only independent prognostic factor of survival in the multivariate analysis, whereas histological criteria and the immunohistochemical expression of apomucins and CDX2 are helpful in the classification and understanding of the histogenesis of ACs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653761     DOI: 10.1007/s00428-007-0444-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  30 in total

1.  Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts.

Authors:  J Albores-Saavedra; L Murakata; J E Krueger; D E Henson
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

2.  Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.

Authors:  Hui Zhou; Nico Schaefer; Martin Wolff; Hans-Peter Fischer
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

3.  Surgical pathology aspects of cancer of the ampulla-head-of-pancreas region.

Authors:  A L Cubilla; P J Fitzgerald
Journal:  Monogr Pathol       Date:  1980

4.  Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences.

Authors:  A M Chiaravalli; D Furlan; C Facco; M G Tibiletti; A Dionigi; B Casati; L Albarello; C Riva; C Capella
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

5.  Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver.

Authors:  J Albores-Saavedra; M P Hoang; L A Murakata; P Sinkre; H Yaziji
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

6.  Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

Authors:  H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

7.  Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas.

Authors:  Yesim Gürbüz; Günter Klöppel
Journal:  Virchows Arch       Date:  2004-04-08       Impact factor: 4.064

8.  Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head.

Authors:  J Klempnauer; G J Ridder; R Pichlmayr
Journal:  Br J Surg       Date:  1995-12       Impact factor: 6.939

9.  Influence of site of origin and mucin production on survival in ampullary carcinoma.

Authors:  P J Dawson; M M Connolly
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

10.  Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis.

Authors:  N R dos Santos; R Seruca; M Constância; M Seixas; M Sobrinho-Simões
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

View more
  27 in total

Review 1.  [Tumors of Vater's ampulla].

Authors:  N Gassler; R Knüchel
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

2.  Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.

Authors:  João Paulo Lemos da Silveira Santos; Carla Jorge Machado; Eduardo Paulino Junior; João Bernardo Sancio Rocha Rodrigues; Paula Teixeira Vidigal; Vivian Resende
Journal:  J Gastrointest Surg       Date:  2018-05-07       Impact factor: 3.452

3.  Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Authors:  Nobuyuki Ohike; Ipek Coban; Grace E Kim; Olca Basturk; Takuma Tajiri; Alyssa Krasinskas; Sudeshna Bandyopadhyay; Toshio Morohoshi; Yuki Shimada; David A Kooby; Charles A Staley; Michael Goodman; N Volkan Adsay; Nazmi Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

Review 4.  Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Authors:  Francesca Panzeri; Stefano Crippa; Paola Castelli; Francesca Aleotti; Alessandro Pucci; Stefano Partelli; Giuseppe Zamboni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 5.  Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.

Authors:  Valerie Lee; Adrian Murphy; Dung T Le; Luis A Diaz
Journal:  Oncologist       Date:  2016-07-13

6.  Substaging Nodal Status in Ampullary Carcinomas has Significant Prognostic Value: Proposed Revised Staging Based on an Analysis of 313 Well-Characterized Cases.

Authors:  Serdar Balci; Olca Basturk; Burcu Saka; Pelin Bagci; Lauren M Postlewait; Takuma Tajiri; Kee-Taek Jang; Nobuyuki Ohike; Grace E Kim; Alyssa Krasinskas; Hyejeong Choi; Juan M Sarmiento; David A Kooby; Bassel F El-Rayes; Jessica H Knight; Michael Goodman; Gizem Akkas; Michelle D Reid; Shishir K Maithel; Volkan Adsay
Journal:  Ann Surg Oncol       Date:  2015-03-18       Impact factor: 5.344

7.  The Role of Log Odds of Positive Lymph Nodes in Predicting the Survival after Resection for Ampullary Adenocarcinoma.

Authors:  Cihan Agalar; Anıl Aysal; Tarkan Unek; Tufan Egeli; Mucahit Ozbilgin; Nesrin Akturk; Huseyin Salih Semiz; Tugba Unek; Mesut Akarsu; Müjde Soyturk; Hulya Ellidokuz; Ozgul Sagol; Ibrahim Astarcioglu
Journal:  Pathol Oncol Res       Date:  2019-01-28       Impact factor: 3.201

8.  Tumors of ampulla of Vater: A case series and review of chemotherapy options.

Authors:  Adriana Romiti; Viola Barucca; Angelo Zullo; Ida Sarcina; Roberta Di Rocco; Chiara D'Antonio; Marco Latorre; Paolo Marchetti
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

9.  A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy.

Authors:  Z-Q Jiang; G Varadhachary; X Wang; S Kopetz; J E Lee; H Wang; R Shroff; M Katz; R A Wolff; J Fleming; M J Overman
Journal:  Ann Oncol       Date:  2013-05-22       Impact factor: 32.976

10.  Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.

Authors:  Arne Westgaard; Aasa R Schjølberg; Milada Cvancarova; Tor J Eide; Ole Petter F Clausen; Ivar P Gladhaug
Journal:  Histopathology       Date:  2009-02       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.